2024-511616-24-00招募中1 期
The goal of this clinical study is to learn more about the safety and dosing of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory B-cell lymphoma.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 14
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU CT Support
Scientific
Kite Pharma Inc.
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial ProtocolNCT06990854Dexiong Han207
招募中
1 期
A clinical trial to learn how an investigational drug (MP-101) affects on the laboratory signs of the disease when given to Huntington’s Disease (HD), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) and Alzheimer’s Disease (AD) patients2023-507195-43-00Mitochon Pharmaceuticals Inc.40
进行中（未招募）
2 期
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisPBCPrimary Biliary CholangitisNCT05050136Mirum Pharmaceuticals, Inc.333
尚未招募
3 期
Scope of Homoeopathy in reducing Hearing DisabilityCTRI/2022/11/046971Dr Rathu N Ravi
已完成
不适用
Exploratory clinical studies to obtain detailed digital and bioinformation data to investigate common characteristics of healthy super-elderly peopleJPRN-UMIN000045789The University of Tokyo30